Cargando…
Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancer
BACKGROUND: The MALAT1 lncRNA acts as an oncogene in Prostate cancer (PC); thus, it can be severe as a cancer biomarker. METHODS: Using bioinformatics datasets including (HTSeq-Counts, GDC, and TCGA) 5501 gene expression profiling specimens were gathered. Then, expression profiles and sample surviva...
Autores principales: | Ahmadi-Balootaki, Soraya, Doosti, Abbas, Jafarinia, Mojtaba, Goodarzi, Hamed Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511773/ https://www.ncbi.nlm.nih.gov/pubmed/36163080 http://dx.doi.org/10.1186/s41021-022-00252-3 |
Ejemplares similares
-
Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells
por: Javadi, Marzieh, et al.
Publicado: (2023) -
Use of dual-transfection for programmed death cell protein 1 disruption mediated by CRISPR-Cas9 in human peripheral blood mononuclear cells
por: Alambeladi, SeyedAli, et al.
Publicado: (2021) -
CRISPR/Cas9-mediated LINC00511 knockout strategies, increased apoptosis of breast cancer cells via suppressing antiapoptotic genes
por: Azadbakht, Narjes, et al.
Publicado: (2022) -
Evaluation of Apoptosis, Cell Proliferation and Cell Cycle Progression by Inactivation of the NEAT1 Long Noncoding RNA in a Renal Carcinoma Cell Line Using CRISPR/Cas9
por: Haghighi, Nastaran, et al.
Publicado: (2023) -
CRISPR/Cas9 mediated targeting of multiple genes in Dictyostelium
por: Sekine, Ryoya, et al.
Publicado: (2018)